Target intelligence / Profile preview

Multiple bacterial surface antigens

Molecular classification
Surface protein, Polysaccharide, Lipopolysaccharide, Peptidoglycan, Lipoprotein
01

Overview

Multiple bacterial surface antigens refer to a heterogeneous group of molecules located on the exterior of bacterial cells, including proteins, polysaccharides, and lipopolysaccharides, which serve as the primary interface between the pathogen and the host immune system. These antigens play critical roles in bacterial physiology, such as maintaining structural integrity, facilitating adhesion to host tissues, and enabling the transport of essential nutrients. In the context of pharmacology, they are the primary targets for vaccines and immunotherapies, where they are used to prime the immune system to recognize and neutralize specific pathogens. By inducing the production of high-affinity antibodies and activating cellular immune responses, targeting these antigens helps prevent or mitigate bacterial infections. However, because this term describes a broad category rather than a single molecular entity, it is often considered a non-specific or aggregate target in drug discovery databases.

Other names
Bacterial surface proteinsBacterial cell wall antigensPathogen-associated molecular patternsBacterial lysatesPolyvalent bacterial antigens
02

Mechanism of action

Induction of active immunity through B-cell and T-cell activation; opsonization and neutralization of pathogens by induced antibodies.

03

Biological functions

Cell wall integrityBacterial adhesionVirulence factorNutrient transportImmune evasion
04

Disease associations

Bacterial infectionSepsisPneumoniaMeningitisRespiratory tract infection
05

Safety considerations

AnaphylaxisInjection site reactionsAutoimmune cross-reactivityDisruption of commensal microbiome (if targeted non-specifically)
06

Interacting drugs

Pneumococcal 13-valent Conjugate Vaccine

4 more in the full profile.

07

Biomarkers

Antibody titers (IgG/IgM)C-reactive proteinProcalcitoninBactericidal activity assay

Beyond the preview

Go deeper on Multiple bacterial surface antigens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple bacterial surface antigens.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call